We have also observed in vivo that reducing both phospho-STAT3 and miR-21 levels in C57BL6 mice liver, by long-term treatment with metformin, a widely used anti-diabetic drug, strongly improved age dependent hepatic steatosis. The gene discussed is STAT3; the disease is Hepatic steatosis.